Hamburg, Germany | Oxford, UK - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) today announced it has received a Certificate of GMP Compliance from the Medicines and Healthcare Products Regulatory Agency (MHRA). This replaces the old statement of cGMP compliance previously issued.
 
Dr Mario Polywka, Chief Operating Officer at Evotec, said: "It is gratifying to receive validation of our high quality process development, manufacturing, analytical and quality assurance capabilities through this certification. We are proud to be one of the first companies to receive the new MHRA certificate in place of the old statement of compliance. This certificate means we continue to provide our customers with the best possible facilities and processes to manufacture their drug compounds. I would like to thank our fantastic Quality Department for maintaining such high standards."
 
Contact: Anne Hennecke, Director, Investor Relations & Corporate Communications, Evotec AG, Phone: +49.(0)40.56081-286, anne.hennecke@evotec.com